67088 Federal Register / Vol. 62, No. 246 / Tuesday, December 23, 1997 / Notices

435–0888, will provide a summary of

the meeting and a roster of the members

upon request. Other information

pertaining to the meeting can be

obtained from the Executive Secretary

indicated. Individuals who plan to

attend and need special assistance, such

as sign language, interpretation or other

reasonable accommodations, should

contact the Executive Secretary in

advance of the meeting.

Name of Committee: The

Subcommittee on Planning of the

National Advisory Research Resources

Council

Date of Meeting: January 29, 1998

Place of Meeting: National Institutes

of Health, 9000 Rockville Pike,

Conference Room 3B31, Building 31,

Bethesda, Maryland 20892.

Open: January 29, 7:30 a.m.–8:45 a.m.

Purpose/Agenda: To discuss policy

issues.

Name of Committee: National

Advisory Research Resources Council

Date of Meeting: January 29–30, 1998

Place of Meeting: National Institutes

of Health, 9000 Rockville Pike,

Conference Room 10, Building 31C,

Bethesda, Maryland 20892.

Open: January 29, 9 a.m. until recess

Closed: January 30, 8:30 a.m. until

9:30 a.m.

Open: January 30, 10:00 a.m. until

adjournment

Purpose/Agenda: Report of Center

Director and other issues related to

Council business.

Executive Secretary: Louise Ramm,

Ph.D. Deputy Director, National Center

for Research Resources, Building 31,

Room 3B11, Bethesda, MD 20892,

Telephone: (301) 496–6023.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, Laboratory Animal

Sciences and Primate Research; 93.333,

Clinical Research; 93.337, Biomedical

Research Support; 93.371, Biomedical

Research Technology; 93.389, Research

Centers in Minority Institutions; 93.198,

Biological Models and Materials Research;

93.167, Research Facilities Improvement

Program; 93.214 Extramural Research

Facilities Construction Projects, National

Institutes of Health)

Dated: December 15, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–33382 Filed 12–22–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Center

for Scientific Review Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review

individual grant applications.

Name of SEP: Biological and

Physiological Sciences.

Date: January 5, 1998.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 4152,

Telephone Conference.

Contact Person: Dr. Marcelina Powers,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4152, Bethesda,

Maryland 20892, (301) 435–1720.

Name of SEP: Biological and

Physiological Sciences.

Date: January 8, 1998

Time: 10:00 a.m.

Place: NIH, Rockledge 2, Room 4152,

Telephone Conference.

Contact Person: Dr. Marcelina Powers,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4152, Bethesda,

Maryland 20892, (301) 435–1720.

Name of SEP: Multidisciplinary

Sciences.

Date: March 9–10, 1998.

Time: 8:00 a.m.

Place: Woodfin Suites, Rockville,

Maryland.

Contact Person: Dr. Nadarajen

Vydelingum, Scientific Review

Administrator, 6701 Rockledge Drive,

Room 5210, Bethesda, Maryland 20892,

(301) 435–1176.

Name of SEP: Microbiological and

Immunological Sciences.

Date: March 19–20, 1998.

Time: 8:30 a.m.

Place: Holiday Inn, Bethesda,

Maryland.

Contact Person: Dr. Jean Hickman,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4178, Bethesda,

Maryland 20892, (301) 435–1146.

The meetings will be closed in

accordance with the provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), Title

5, U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: December 15, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–33380 Filed 12–22–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Prospective Grant of Exclusive

License: Pharmaceutical Compositions

And Methods For Treatment of

Hyperproliferative Epithelial Skin

Diseases and Cancer

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: This is notice in accordance

with 35 U.S.C. § 209(c)(1) and 37 CFR

404.7(a)(1)(I) that the National Institutes

of Health, Department of Health and

Human Services, is contemplating the

grant of an exclusive worldwide license

to practice the inventions embodied in

the U.S. Patent Application SN 07/

677,429 ‘‘Pharmaceutical Compositions

And Methods For Preventing Skin

Tumor Formation And Causing

Regression Of Existing Tumors’’ filed 3/

29/91 and U.S. Patent Application SN

08/389,845 ‘‘Method For The Treatment

Of Hyperproliferative Epithelial Skin

Disease By Topical Application Of

Hydroxylated Aromatic Protein * * *’’

filed 2/2/95 now U.S. Patent 5,610,185

issued 3/11/97 to Nascent

Pharmaceuticals, L.L.C. of San

Francisco, CA. The patent rights in this

invention have been assigned to the

United States of America.

The prospective exclusive license

field of use may be limited to:

Therapeutics for treatment and

prevention of various hyperproliferative

skin diseases in humans.

DATE: Only written comments and/or

applications for a license which are

received by NIH on or before March 23,

1998 will be considered.

ADDRESS: Requests for copies of the

patent or patent application, inquiries,

comments and other materials relating

to the contemplated licenses should be

directed to: Joseph G. Contrera, M.S.,

J.D., Technology Licensing Specialist,

Office of Technology Transfer, National

Institutes of Health, 6011 Executive

Boulevard, Suite 325, Rockville,

Maryland 20852–3804; Telephone: (301)